105
Participants
Start Date
February 17, 2017
Primary Completion Date
August 31, 2020
Study Completion Date
November 2, 2020
IVIG
Subjects randomized to this arm will receive IVIG 2g/kg over 10-12 hours
Infliximab
Subjects randomized to this arm will receive infliximab 10 mg/kg over 2 hours
Maria Fareri Children's Hospital, Valhalla
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Children's National Health SYstem, Washington D.C.
Children's Healthcare of Atlanta, Atlanta
UAB Children's of Alabama, Birmingham
Vanderbilt University Medical Center, Nashville
Nationwide Children's Hospital, Columbus
Riley Children's Health Indiana University School of Medicine, Indianapolis
Children's Hospital of Michigan, Detroit
University of South Dakota Sanford School of Medicine, Sioux Falls
Comer Children's Hospital, Chicago
Children's Mercy Kansas Ciry, Kansas City
University of Nebraska Medical Center, Omaha
Arkansas Children's Hospital, Little Rock
Children's Medical Center of Dallas, Dallas
Texas Children's Hospital, Houston
Children's Hospital of Colorado, Aurora
Primary Care University of Utah, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
David Geffen School of Medicine at UCLA, Los Angeles
Harbor-UCLA Medical Center, Los Angeles
Memorial Care, Long Beach
University of California San Diego, La Jolla
Children's Hospital of Orange County, Orange
Cedar-Sinai Medical Center, West Hollywood
UCSF Benioff Children's Hospital-Oakland, Oakland
UCSF Benioff Children's Hospital-San Francisco, San Francisco
Seattle Children's, Seattle
Boston Children's hospital, Boston
Patient-Centered Outcomes Research Institute
OTHER
University of California, San Diego
OTHER